Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
Al Naghi to distribute QT Imaging Breast Acoustic scanners in UAE
QT Imaging has signed an exclusive distribution agreement with Al Naghi Medical (NMC) for its QTI Breast Acoustic CT [computed …
-
Lipocine completes Phase III enrolment for LPCN 1154 in PPD
Lipocine has announced the completion of enrolment and participant dosing in its Phase III clinical trial investigating LPCN 1154, an …
-
Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies
Novo Nordisk and Aspect Biosystems have commenced a new phase in their ongoing partnership focused on curative cellular medicines to …
-
Passwordless authentication at top of healthcare IT leaders’ priorities, report shows
A new survey by security firm Imprivata has found that a majority of IT leaders in healthcare view ‘passwordless’ authentication …
-
Hospital cybersecurity: the threat in every HCP’s pocket
The use of mobile devices in hospitals to streamline workflows and improve patient care has become commonplace. For cyber-attackers, this …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
Guardant and MSD collaborate on companion diagnostics development
Guardant Health has entered a multi-year strategic partnership agreement with Merck & Co (MSD) for the development of companion diagnostics. The …
-
Nxera reports positive outcomes for daridorexant Phase III insomnia study
Nxera Pharma has announced positive top-line results from its Phase III study of daridorexant 50mg, aimed at treating insomnia in …
-
iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s
iRegene Therapeutics has received regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its …
-
Zylox-Tonbridge to acquire German medical technology company Optimed
Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology …
-
Genmab reports top line results in Phase III DLBCL trial
Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting improved progression-free survival …
-
FDA grants Novartis’ ianalumab breakthrough therapy status for Sjögren’s disease
Novartis has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ianalumab, a treatment …
-
BD secures FDA 510(k) clearance for EnCor EnCompass system
BD (Becton, Dickinson and Company) has received 510(k) approval from the US Food and Drug Administration (FDA) for the EnCor …
-
Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management
Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 (esreboxetine) for the management of fibromyalgia, with the first …
-
Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal
Agenus has completed a $141m strategic collaboration with Zydus Lifesciences to accelerate the global development and potential commercialisation of its …
-
CareView partners with MedPro to expand US virtual care services
US-based virtual care solution provider CareView has announced a new virtual care partnership in healthcare with national sales organisation MedPro. The …
